Loading news...
Insights from the Fourth Quarter 2025 13F Filing Richard Pzena (Trades, Portfolio) recently submitted the 13F filing for the fourth quarter of 2025, providing
Baxter International sells medical products and devices. The company's products are necessities for the healthcare industry.
Baxter International (NYSE: BAX - Get Free Report) and Hero Technologies (OTCMKTS:HENC - Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, profitability, risk, dividends, earnings and analyst recommendations. Profitability This table compares Baxter International and Hero
Significant Transaction in Tyson Foods On December 31, 2025, Richard Pzena (Trades, Portfolio) executed a notable transaction involving Tyson Foods Inc. The fir
BAX is reshaping its portfolio following the divestiture of its Kidney Care business, focusing on surgical strength, deleveraging and tighter execution to rebuild momentum.
Cooke and Bieler LP boosted its holdings in Baxter International Inc. (NYSE: BAX) by 25.7% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 2,200,860 shares of the medical instruments supplier's stock after buying an additional 450,350 shares during the
On December 31, 2025, Richard Pzena (Trades, Portfolio), a prominent figure in the investment world, executed a significant stock transaction involving Malibu B
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medtech company, will host a conference call to discuss its fourth-quarter 2025 financial results on Thursday, February 12, 2026 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://registrations.events/direct/Q4I81994118 to pre-register for the call and receive the call information. This call is also being webcast and can be accessed through Baxter's website at.
Baxter International offers a compelling defensive play, trading at historically low valuations after significant deleveraging and operational headwinds. BAX's forward cash earnings multiple is around 8x, notably cheaper than hospital and consumer health product peers, despite slightly weaker gross profit margins. Management's focus on debt reduction and cost controls positions BAX for margin expansion and potential sales growth into 2027.
BAX introduces its Dynamo Series smart stretcher, aiming to boost hospital safety and reduce patient transfers.
DEERFIELD, Ill.--(BUSINESS WIRE)--BAXTER INTRODUCES THE DYNAMO SERIES, A NEW SMART STRETCHER TO HELP ADDRESS COMMON CHALLENGES IN HOSPITAL SETTINGS.
Baxter International Inc. (BAX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
CHARLESTON, S.C.--(BUSINESS WIRE)--MUSC Health and Baxter International Inc. (NYSE:BAX), a global medtech leader, are entering into a multi-year strategic partnership that aims to enhance the high-quality and safe patient care already delivered at MUSC Health, MUSC's health care system, through integrated connected care technologies. By leveraging Baxter's cutting-edge solutions and MUSC Health's clinical and academic expertise, the partnership aims to help drive further improvements in nurse s.
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the J.P. Morgan 2026 Healthcare Conference on Monday, January 12, 2026. Andrew Hider, Baxter's president and chief executive officer, is scheduled to present at 2:15 p.m. Pacific Time. The live webcast of Baxter's presentation can be accessed at www.baxter.com and will be available for replay through Saturday, July 11, 2026. About Baxter At Baxter, we are everywhere healthcare happen.
BAX is reshaping its portfolio following the divestiture of Kidney Care, focusing on surgical strength, deleveraging and tighter execution to rebuild momentum.
NEW YORK, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating certain officers and directors Baxter International, Inc. (NYSE: BAX) and Molina Healthcare, Inc. (NYSE: MOH) on behalf of long-term stockholders. More information about each potential case can be found at the link provided.
Baxter International (NYSE: BAX - Get Free Report) and NWT Uranium (OTCMKTS:CPTRF - Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, profitability, risk, earnings, institutional ownership, analyst recommendations and dividends. Analyst Recommendations This is a summary of recent
NEW YORK, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Baxter International, Inc. ("Baxter International, Inc." or the "Company") (NYSE: BAX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Baxter International, Inc. investors who were adversely affected by alleged securities fraud between February 23, 2022 and October 29, 2025.
NEW YORK, Dec. 15, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Baxter International Inc. (NYSE: BAX) between February 23, 2022 and July 30, 2025, both dates inclusive (the “Class Period”), of the important December 15, 2025 lead plaintiff deadline.
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Baxter (BAX) To Contact Him Directly To Discuss Their Options